Investigating the role of a specific enzyme in eye health and disease
Official title: IMPDH1 in photoreceptor function and disease
Funded at University of Washington · NIH-11092238 · Data updated 2026-11-12
This study is looking at how a specific enzyme called IMPDH1 affects the health of the light-sensitive cells in our eyes, which are important for seeing, and it aims to help people understand how certain genetic changes can lead to vision loss.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project start | June 1, 2024 |
| Project end | February 29, 2028 |
| Funding year | 2025 |
| Award (this year) | $411,390 |
| NIH project number | 5R01EY033731-02 |
| Project ID | NIH-11092238 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals with genetic mutations affecting IMPDH1 and those experiencing retinal degeneration.
✕Less likely to help
Patients with retinal diseases not linked to IMPDH1 mutations may not benefit from this research.
What this research studies
This research focuses on understanding how inosine monophosphate dehydrogenase 1 (IMPDH1) affects the health of photoreceptors in the retina, which are crucial for vision. By studying both human and zebrafish models, the researchers aim to uncover the biochemical processes regulated by IMPDH1 and how mutations in this enzyme lead to retinal degeneration. The study employs advanced techniques such as cryo-electron microscopy to analyze the structure and function of IMPDH1, providing insights into its role in maintaining retinal health. Patients may benefit from a better understanding of the mechanisms behind certain types of blindness caused by genetic mutations.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for treating retinal diseases and preventing blindness.
How similar studies have gone: Previous research has shown promising results in understanding retinal degeneration through similar biochemical and genetic approaches.
Where this research is happening
-
University of Washington
Seattle, United States Active
Researchers
- Principal investigator: Brockerhoff, Susan E — University of Washington
- Study coordinator: Brockerhoff, Susan E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.